Analysts forecast that Senesco Technologies Inc. (NYSE:ELOX) will announce earnings of ($0.37) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Senesco Technologies’ earnings, with the highest EPS estimate coming in at ($0.33) and the lowest estimate coming in at ($0.40). Senesco Technologies posted earnings of ($0.23) per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 60.9%. The business is scheduled to issue its next earnings results on Tuesday, August 6th.
On average, analysts expect that Senesco Technologies will report full-year earnings of ($1.47) per share for the current financial year, with EPS estimates ranging from ($1.64) to ($1.32). For the next fiscal year, analysts anticipate that the firm will post earnings of ($1.51) per share, with EPS estimates ranging from ($1.76) to ($1.36). Zacks’ EPS calculations are an average based on a survey of sell-side research firms that follow Senesco Technologies.
Senesco Technologies (NYSE:ELOX) last issued its earnings results on Thursday, May 9th. The company reported ($0.33) EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.08.
Senesco Technologies Company Profile
Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.
Featured Article: Do equity income investments outperform growth and income investments?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.